Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
University College London Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Reading Featured PhD Programmes
United Kingdom ×
10 miles

Pathology PhD Projects, Programs & Scholarships in the UK

We have 146 Pathology PhD Projects, Programs & Scholarships in the UK

  • Pathology×
  • United Kingdom×
  • clear all
Order by 
Showing 1 to 10 of 146
  Marie Skłodowska-Curie ITN, Early Stage Researcher (iPLACENTA, ESR11): “Enhancing imaging of the placenta in murine models of preeclampsia and standardisation of preeclampsia mouse models”
  Prof A Ahmed
Application Deadline: 14 December 2018
Aston Medical School is looking for an Early Stage Researcher (ESR) to work on the project “Enhancing imaging of the placenta in murine models of preeclampsia and standardisation of preeclampsia mouse models (ESR11)” as part of iPLACENTA network collaborating with 14 other ESRs based in 11 European academic, industrial and clinical institutes.
  The influence of serious battlefield traumatic injury (SBTI ) upon cardiovascular disease (CVD) risk and heart rate variability
  Prof A McConnell
Application Deadline: 31 January 2019
The aims of the project are to examine the impact of STBI upon HRV and its relationship to other CVD risk markers in a cohort British Military Servicemen who have sustained recent SBTI.
  Can we predict cancer cell migration and spread using deep and machine learning of pathology images?
  Prof R H Insall, Dr J Edwards
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
  Extracellular vesicles as indicators of immune status and outcome in sepsis patients
  Dr K P O'Dea, Prof AC Gordon, Dr M Takata
Application Deadline: 7 January 2019
Sepsis is a major health care burden with unacceptably high rates of mortality. The underlying pathogenic mechanisms are multifactorial involving dysfunctional immune and metabolic responses to infection.
  Curing Genetic Muscle diseases
  Dr J Ochala
Applications accepted all year round
Congenital myopathies are a group of genetic muscle diseases with unclear mechanisms and no efficient treatment.
  Biological significance, predictive value and targeting of the HER family members in pancreatic cancer
  Prof H Modjtahedi
Applications accepted all year round
Despite major advances in imaging technologies, surgery, chemotherapy, radiotherapy and targeted therapy of cancer in the last few decades, pancreatic cancer remains as one of the most aggressive and fatal types of human cancer.
  Investigating the efficacy of novel antimicrobial mixes on microorganisms, surfaces and cells lines; an integrated study
  Dr A Kelly, Dr S Schwikkard, Prof D Wertheim
Applications accepted all year round
The projection that within 50 years there will be more deaths from antimicrobial resistance than through cancer highlights the continual need for mining new and novel antimicrobials with activity against planktonic microbes and biofilms alike1.
  Natural products as prophylaxis and treatment for gonococcal eye infections
  Dr L Snyder
Applications accepted all year round
Neisseria gonorrhoeae bacteria can infect the eyes of infants born to mothers infected with gonorrhoea, up to 80% of whom have no symptoms of their disease.
  Potential therapeutic effects of natural products in Human Papillomavirus (HPV) related cervical cancers
  Dr H Ashrafi
Applications accepted all year round
Cervical cancer is one of the most common types of cancer affecting women worldwide. Infection caused by high-risk human papillomaviruses (HPVs), especially type 16 and 18 are implicated in the etiology of most cervical cancers.
  The role of matrix interactions in regulating the SPARC family of matricellular proteins.
  Dr N Hill, Dr A Munasinghe
Applications accepted all year round
The SPARC family of matricellular proteins determine the way in which cells respond to their extracellular environment. SPARC family proteins interact with a range of binding partners, including matrix proteins (1).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.